Originally Posted by jealousisjelly
Was he a young *** teen kid like you? Immature and had no idea what he was doing, just wanted to try something that he wasn't ready for?
There are plenty of studies about mushrooms being used for therapy with positive results.
Cite them then.
I see this small study with only 12 people:
Magic mushroom ingredient tested as depression treatment
Wed, 18 May 2016 12:33:00 EST
"Magic mushrooms 'promising' in depression," BBC News reports. Magic mushrooms is an umbrella term for fungi that contain psilocybin, a psychoactive substance that can cause intense LSD-like hallucinations
, as well as reported feelings of euphoria and "spiritual insight".
Researchers gave two doses of psilocybin to 12 volunteers, all of whom had moderate or severe depression
that had not responded to other treatment. As this drug is controlled in the UK, permission from the Home Office was needed for the study, and the participants were closely monitored by psychiatrists.
The intention was to monitor the "intensity" of the experience, as reported by the volunteers, to see if it was feasible to use psilocybin to treat people with severe depression. The researchers also wanted to get an initial impression of its effects.
They found the 12 volunteers tolerated the drug, with minor side effects that did not last long. Eight of them had no symptoms of depression one week after treatment, and five were free from depression after three months.
But because of the type of study this is and its small size, we can't be sure if these results are the result of psilocybin.
The researchers warn that people should not try to treat themselves with mushrooms that contain psilocybin. Aside from their unpredictable effects, magic mushrooms are class A drugs that are illegal to possess – which can carry a seven-year jail sentence – or distribute, which can result in up to life imprisonment.
Where did the story come from?
The study was carried out by researchers from Imperial College London, South London and Maudsley NHS Trust, King's College London, University College London, the Royal London Hospital, and the Beckley Foundation.
It was funded by the Medical Research Council.
The study was published in the peer-reviewed
journal The Lancet: Psychiatry on an open-access
basis, so it's free to read online
While overall the UK media reporting was accurate, The Sun newspaper wins the most inappropriate headline of the month award (and is currently a leading contender for 2016).
Their headline, "Magic mushrooms make you a fun guy", manages to both trivialise the life-limiting and often horrible impact severe depression can have, while simplifying the complex results of this study.
The Sun also used a stock photo of a classic twentysomething cheesy raver with the caption: "Professor Nutt, who worked on the study, was previously sacked as the Government's chief drug adviser in 2009". The distinguished 65-year-old psychiatrist may be a little put out (or possibly amused) by this.
The Daily Mail was also overenthusiastic in its reporting, saying that "Hundreds of thousands of people could benefit from antidepressants derived from magic mushrooms", despite the limited nature of the study.
However, both The Guardian and The Independent give a more measured account of the study and its limitations.
What kind of research was this?
This was an open-label feasibility study
designed to test whether the drug psilocybin could be safely given to selected patients with depression, alongside psychological support.
Everyone in the study took the drug, meaning there was no comparison group and everyone knew that they were taking the drug.
That said, it is hard to imagine what could serve as a placebo for a drug (psilocybin) notorious for its hallucinogenic properties.
This type of early-stage trial cannot give us reliable information on efficacy – nor is it set up to do so.
Even if such a trial suggests possible effectiveness, it's hard to be sure whether the results are truly down to the drug or whether they could reflect an "expectation" effect, where people immediately felt better because that is what they expected.
What did the research involve?
Researchers publicised their study, saying they wanted to recruit people with depression that had not responded to other treatments to test psilocybin. Only 12 of the 72 volunteers met the study requirements.
After physical and mental health tests – including checks to make sure the volunteers were not at high risk of psychosis – they were given two doses of psilocybin in hospital, one week apart.
The first was a low dose to check for unexpected reactions, while the second was a high dose aimed at treating depression. The day after treatment, people were asked about their experiences, including the intensity of psychedelic effects (on a scale of 0 to 1) and any unpleasant effects.
Everyone was followed up regularly, by telephone or email, from the day after the high-dose treatment until three months afterwards. Participants filled in questionnaires designed to monitor depression symptoms.
Researchers compared depression scores from before the study began, one week after treatment, and three months after treatment.